FYERS
Home
/
Stocks
/
Results
/
Bharat Parenterals Results

Bharat Parenterals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-8%17%30%
----515%
-32%37%13%
11%5%-1%-17%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
LUPIN-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
BPLPHARMA-B
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,902.1₹456833 Cr37.7712.0762.82₹11479 Cr
9,152₹245426 Cr83.9134.04128.41₹2568 Cr
4,831.15₹187320 Cr85.8916.7297.06₹2163 Cr
1,128.85₹113217 Cr25.099.4262.53₹5040 Cr
1,380.4₹112212 Cr33.299.7757.87₹3879 Cr
1,845.2₹101155 Cr92.526.829.25₹889 Cr
2,109.7₹97626 Cr17.6630.95154.36₹5333 Cr
2,329.4₹96859 Cr47.4213.7571.08₹1913 Cr
1,156.8₹96406 Cr29.925.3263.99₹4196 Cr
1,655₹93614 Cr25.2217.9596.84₹3505 Cr
1,505.1₹1058 Cr—1.4627.47-₹27 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Dec 2017Sep 2017Dec 2016
₹94 Cr₹100 Cr₹65 Cr₹65 Cr₹116 Cr₹104 Cr₹72 Cr₹72 Cr₹93 Cr₹68 Cr₹60 Cr₹60 Cr₹70 Cr₹51 Cr₹59 Cr₹82 Cr₹26 Cr₹52 Cr₹38 Cr₹60 Cr₹61 Cr₹41 Cr₹50 Cr₹60 Cr₹55 Cr₹55 Cr₹74 Cr₹50 Cr₹50 Cr₹42 Cr₹90 Cr₹51 Cr₹37 Cr₹33 Cr₹37 Cr₹29 Cr
₹1 Cr₹4 Cr₹1 Cr₹4 Cr₹1 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹1 Cr₹3 Cr₹2 Cr₹31 L₹3 Cr₹6 Cr₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr₹5 Cr₹1 Cr₹3 Cr₹0₹0₹0
₹95 Cr₹103 Cr₹67 Cr₹68 Cr₹117 Cr₹106 Cr₹75 Cr₹76 Cr₹95 Cr₹70 Cr₹61 Cr₹62 Cr₹72 Cr₹51 Cr₹63 Cr₹88 Cr₹28 Cr₹55 Cr₹40 Cr₹63 Cr₹63 Cr₹42 Cr₹52 Cr₹62 Cr₹57 Cr₹57 Cr₹77 Cr₹53 Cr₹53 Cr₹46 Cr₹94 Cr₹52 Cr₹40 Cr₹33 Cr₹37 Cr₹29 Cr
₹94 Cr₹109 Cr₹72 Cr₹72 Cr₹111 Cr₹110 Cr₹77 Cr₹88 Cr₹97 Cr₹71 Cr₹55 Cr₹57 Cr₹61 Cr₹46 Cr₹58 Cr₹74 Cr₹26 Cr₹49 Cr₹37 Cr₹52 Cr₹52 Cr₹39 Cr₹46 Cr₹52 Cr₹48 Cr₹49 Cr₹64 Cr₹47 Cr₹46 Cr₹40 Cr₹83 Cr₹41 Cr₹33 Cr₹29 Cr₹34 Cr₹27 Cr
₹10 Cr₹3 Cr₹3 Cr₹4 Cr₹15 Cr₹4 Cr₹7 Cr-₹3 Cr₹7 Cr₹4 Cr₹8 Cr₹7 Cr₹13 Cr₹7 Cr₹6 Cr₹16 Cr₹3 Cr₹7 Cr₹4 Cr₹13 Cr₹12 Cr₹4 Cr₹8 Cr₹11 Cr₹11 Cr₹9 Cr₹14 Cr₹8 Cr₹9 Cr₹8 Cr₹12 Cr₹13 Cr₹8 Cr₹5 Cr₹5 Cr₹3 Cr
₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹1 Cr₹58 L₹63 L₹89 L₹80 L₹79 L₹34 L₹25 L₹31 L₹21 L₹15 L₹29 L₹40 L₹17 L₹13 L₹7 L₹25 L₹18 L₹27 L₹16 L₹13 L₹20 L₹37 L₹17 L₹16 L₹21 L₹22 L
-₹1 Cr-₹8 Cr-₹8 Cr-₹7 Cr₹3 Cr-₹8 Cr-₹6 Cr-₹15 Cr-₹5 Cr-₹1 Cr₹5 Cr₹5 Cr₹10 Cr₹4 Cr₹4 Cr₹14 Cr₹2 Cr₹5 Cr₹2 Cr₹11 Cr₹10 Cr₹2 Cr₹6 Cr₹9 Cr₹9 Cr₹7 Cr₹12 Cr₹6 Cr₹7 Cr₹6 Cr₹11 Cr₹11 Cr₹7 Cr₹4 Cr₹3 Cr₹2 Cr
-₹4 Cr-₹8 Cr-₹10 Cr-₹9 Cr-₹87 L-₹9 Cr-₹8 Cr-₹18 Cr-₹9 Cr-₹3 Cr₹4 Cr₹2 Cr₹7 Cr₹2 Cr₹2 Cr₹10 Cr₹1 Cr₹4 Cr₹1 Cr₹8 Cr₹8 Cr₹2 Cr₹5 Cr₹6 Cr₹7 Cr₹7 Cr₹8 Cr₹4 Cr₹5 Cr₹5 Cr₹7 Cr₹4 Cr₹5 Cr₹3 Cr₹3 Cr₹2 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
——————————
₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr
₹0₹0₹53 L₹0₹43 L₹0₹0₹0₹0₹0
₹324 Cr₹191 Cr₹176 Cr₹160 Cr₹138 Cr₹112 Cr₹88 Cr₹67 Cr₹58 Cr₹51 Cr
₹324 Cr₹191 Cr₹176 Cr₹160 Cr₹138 Cr₹112 Cr₹88 Cr₹67 Cr₹58 Cr₹51 Cr
₹331 Cr₹197 Cr₹183 Cr₹166 Cr₹144 Cr₹118 Cr₹94 Cr₹73 Cr₹64 Cr₹57 Cr
₹8 Cr₹41 Cr₹35 Cr₹4 Cr-₹5 L₹1,000₹1,000₹1,000₹1,000₹0
₹71 Cr₹71 Cr₹11 Cr₹10 Cr₹9 Cr₹71 L₹97 L₹2 Cr₹4 Cr₹7 Cr
₹5 Cr₹3 Cr₹0₹3 Cr₹0₹0₹0₹0₹34 L₹33 L
-₹83 L-₹12 L₹40 L₹96 L₹2 Cr₹2 Cr₹3 Cr-₹2 Cr-₹72 L₹50 L
₹10 Cr₹78 L₹0₹0₹0₹0₹0₹0₹0₹0
₹5 Cr₹2 Cr₹1 Cr₹94 L₹64 L₹51 L₹9 L₹8 L₹0₹0
₹89 Cr₹76 Cr₹13 Cr₹14 Cr₹11 Cr₹3 Cr₹4 Cr₹22 L₹3 Cr₹7 Cr
——————————
₹74 Cr₹59 Cr₹51 Cr₹24 Cr₹26 Cr₹43 Cr₹32 Cr₹27 Cr₹36 Cr₹39 Cr
₹43 Cr₹48 Cr₹31 Cr₹13 Cr₹15 Cr₹23 Cr₹26 Cr₹22 Cr₹6 Cr₹37 L
₹100 Cr₹81 Cr₹36 Cr₹3 Cr₹1 Cr₹0₹2 Cr₹5 Cr₹0₹13 Cr
₹12 Cr₹2 Cr₹2 Cr₹2 Cr₹84 L₹67 L₹71 L₹3 Cr₹21 L₹4 Cr
₹229 Cr₹190 Cr₹120 Cr₹42 Cr₹44 Cr₹66 Cr₹61 Cr₹57 Cr₹43 Cr₹56 Cr
₹658 Cr₹504 Cr₹350 Cr₹226 Cr₹199 Cr₹187 Cr₹159 Cr₹130 Cr₹110 Cr₹120 Cr
₹51 Cr₹22 Cr₹27 Cr₹23 Cr₹31 Cr₹26 Cr₹22 Cr₹21 Cr₹18 Cr₹14 Cr
₹180 Cr₹158 Cr₹50 Cr₹18 Cr₹12 Cr₹1 Cr₹5 Cr₹9 Cr₹6 Cr₹19 Cr
——————————
₹322 Cr₹256 Cr₹80 Cr₹73 Cr₹71 Cr₹54 Cr₹50 Cr₹44 Cr₹36 Cr₹62 Cr
₹71 Cr₹46 Cr₹39 Cr₹33 Cr₹28 Cr₹22 Cr₹16 Cr₹10 Cr₹5 Cr₹28 Cr
₹251 Cr₹210 Cr₹41 Cr₹40 Cr₹43 Cr₹32 Cr₹34 Cr₹34 Cr₹31 Cr₹35 Cr
₹30 Cr₹24 Cr₹99 Cr₹26 Cr₹44 L₹12 Cr₹1 Cr₹0₹0₹0
₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹0₹55 L₹50 L
₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹0₹55 L₹50 L
₹9 Cr₹6 Cr₹22 Cr₹13 Cr₹3 Cr₹8 Cr₹2 Cr₹3 Cr₹10 Cr₹9 Cr
₹0₹0₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr
₹292 Cr₹242 Cr₹166 Cr₹82 Cr₹51 Cr₹56 Cr₹41 Cr₹39 Cr₹46 Cr₹49 Cr
——————————
₹5 Cr₹0₹0₹11 Cr₹43 Cr₹68,000₹1 Cr₹52 L₹0₹0
₹72 Cr₹61 Cr₹38 Cr₹21 Cr₹22 Cr₹29 Cr₹23 Cr₹14 Cr₹15 Cr₹14 Cr
₹172 Cr₹141 Cr₹112 Cr₹73 Cr₹68 Cr₹79 Cr₹64 Cr₹59 Cr₹44 Cr₹44 Cr
₹58 Cr₹15 Cr₹10 Cr₹5 Cr₹2 Cr₹10 Cr₹12 Cr₹4 Cr₹2 Cr₹13 Cr
₹3 Cr₹1 Cr₹74 L₹2 Cr₹45 L₹45 L₹51 L₹53 L₹3 Cr₹57 L
₹56 Cr₹44 Cr₹23 Cr₹32 Cr₹12 Cr₹13 Cr₹18 Cr₹13 Cr₹20 L₹12 L
₹365 Cr₹262 Cr₹184 Cr₹144 Cr₹148 Cr₹132 Cr₹118 Cr₹91 Cr₹64 Cr₹72 Cr
₹136 Cr₹72 Cr₹64 Cr₹102 Cr₹104 Cr₹66 Cr₹58 Cr₹34 Cr₹21 Cr₹15 Cr
₹658 Cr₹504 Cr₹350 Cr₹226 Cr₹199 Cr₹187 Cr₹159 Cr₹130 Cr₹110 Cr₹120 Cr
₹480₹339₹316₹287₹250₹206₹164₹127₹111₹99
₹480₹339₹316₹287₹250₹206₹164₹127₹111₹99

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
-₹34 Cr₹19 Cr₹24 Cr₹28 Cr₹27 Cr₹33 Cr₹35 Cr₹13 Cr₹7 Cr₹0
₹40 Cr₹15 Cr₹9 Cr₹5 Cr₹10 Cr₹6 Cr₹7 Cr₹6 Cr₹6 Cr₹0
-₹23 Cr-₹29 Cr-₹2 Cr-₹28 Cr-₹6 Cr-₹15 Cr-₹10 Cr-₹10 Cr-₹14 Cr₹0
-₹17 Cr₹5 Cr₹30 Cr₹5 Cr₹31 Cr₹24 Cr₹31 Cr₹9 Cr-₹52 L₹0
-₹27 Cr-₹5 Cr₹22 Cr-₹1 Cr₹24 Cr₹14 Cr₹20 Cr₹6 Cr-₹2 Cr₹0
-₹137 Cr-₹105 Cr-₹78 Cr-₹7 Cr-₹43 Cr-₹13 Cr-₹9 Cr-₹8 Cr-₹2 Cr₹0
₹156 Cr₹110 Cr₹61 Cr₹9 Cr₹10 Cr-₹3 Cr-₹4 Cr₹4 Cr-₹8 Cr₹0
-₹8 Cr₹94 L₹4 Cr₹2 Cr-₹8 Cr-₹96 L₹7 Cr₹2 Cr-₹11 Cr₹0
₹9 Cr₹8 Cr₹3 Cr₹2 Cr₹10 Cr₹11 Cr₹4 Cr₹2 Cr₹13 Cr₹0
₹44 L₹9 Cr₹8 Cr₹3 Cr₹2 Cr₹10 Cr₹11 Cr₹4 Cr₹2 Cr₹0

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)1,559.95
Volume (₹)229.00
High (₹)1,559.95
Upper Circuit1,841.90
Low (₹)1,480.00
Lower Circuit1,228.00
Prev Close1,534.95
52W High (₹)1,593.95
Price1,505.10
52W Low (₹)880.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)1057.88 Cr
Div. Yield (%)0.07
PE Ratio0.00
Debt to Equity0.55
Price to Book2.06
Book Value479.79
EPS (TTM)-22.35
Face Value10.00
ROE (%)-16.55

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
BPLPHARMA-BNSE
LTP
1W Low
1W High
Market cap (₹)
1902.1-18 (-0.94%)
1896.30
1964.85
4,56,833Cr
9152-117 (-1.26%)
9051.85
9296
2,45,426Cr
4831.15-203.85 (-4.05%)
4822.25
5049
1,87,320Cr
1128.85-58.15 (-4.90%)
1126
1191.45
1,13,217Cr
1380.4-37.6 (-2.65%)
1376
1426.20
1,12,212Cr
1845.2-90.1 (-4.66%)
1812
1947.90
1,01,155Cr
2109.7-65.3 (-3.00%)
2107.35
2209
97,626Cr
2329.4-58 (-2.43%)
2323.15
2407.40
96,859Cr
1156.8-21 (-1.78%)
1155
1179.90
96,406Cr
1655+5 (0.30%)
1623.05
1706.70
93,614Cr
1505.1-33.55 (-2.18%)
1480
1590
1,058Cr

Bharat Parenterals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹9.65Cr; with other income of ₹1.11Cr, profit before interest and tax came to ₹95.9Lakh. Interest expense was ₹2.45Cr; PBT before exceptional items stood at ₹-₹1.49Cr. Cost mix (full year): raw materials ₹185.93Cr; employee cost ₹49.66Cr; depreciation ₹8.69Cr; other expenses ₹85.2Cr. Basis: consolidated annual results.

Bharat Parenterals Ltd Quaterly Results Key Takeaways

Bharat Parenterals Ltd reported ₹93.74Cr total income from operations in Jun 2026, softer than ₹99.62Cr in Mar 2026 but higher than ₹116Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹9.65Cr; with other income of ₹1.11Cr, profit before interest and tax came to ₹95.9Lakh. Interest expense was ₹2.45Cr, taking profit before tax to ₹-₹1.49Cr. After tax of ₹2.07Cr, profit after tax stood at ₹-₹3.56Cr (vs ₹-₹8.16Cr in Mar 2026 and ₹-₹87.3Lakh in Jun 2025).